SUBSTITUTED β-ALANINES Russian patent published in 2004 - IPC

Abstract RU 2220954 C2

FIELD: organic chemistry, amino acids, pharmacy. SUBSTANCE: invention relates to compounds of the general formula (I): β wherein is hydrogen atom or lower alkyl; R1 represent independently X1, X2, X6 being one among CR3 represents CR2 and other represent independently X3, X4, X5 wherein CR2 is hydrogen atom, lower alkyl or lower alkoxy-group; R2 represents group R3 wherein -L1-(CH2)n-C(=O)-NR4-CH2-CH2- is aryl or heteroaryl; or R4 is alkyl or alkenyl being each is optionally substituted with one or more groups taken among halogen atom, oxo-group, R4 or NH-R5; or C(=O)R7 is cycloalkyl or heterocyclo- alkyl being each is optionally substituted with one or more groups taken among oxo-group, R4 or R6; -L2-R6; is carboxy-group. Aryl. cycloalkyl, heteroaryl, heterocycloalkyl, R5 or -ZR7; -NY1Y2 is aryl or heterocycloalkyl; R6 is alkyl or aryl; R7 is alkylene; L2 and Y1 are independently hydrogen atom, alkyl or aryl; or group Y2 can form 5-7-membered cyclic amine that: (i) can be optionally substituted with one or more substituent taken among oxo-group or alkyl; and (ii) can comprise also oxygen as additional heteroatom; Z represents oxygen atom; -NY1Y2 represents L1-bond wherein R9-R10 means direct or branched R9-alkylene chain; C1-6 is R10; -C(=Z)-NR11- represents hydrogen atom or R11; Y represents carboxy-group; n is a whole number from 1 to 6; and to its prodrugs and pharmaceutically acceptable salts, solvates of such compounds and their prodrugs. Also, invention relates to compounds of the formula (Ia) wherein one among R4 or X4 means the group: C-X5-Y; -R9-CON(R11)-CH2-CON(R4)-CH2-CH2- and X1 mean X2; CR2 and X3 mean CH; another group X6 or X4 is CH; pharmaceutical composition showing ability to regulate interaction of VCAM-1 and fibronectin with integrin VLA-4 (X5); to method for treatment of humans or animals suffering or predisposed to such diseases that can be treated by administration of the cellular adhesion inhibitor. EFFECT: valuable biological and medicinal properties of compounds. 30 cl, 16 tbl

Similar patents RU2220954C2

Title Year Author Number
SUBSTITUTED ANILIDES, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT 1998
  • Ehstlz Piter Charl'Z
  • Klark Dehvid Ehdvard
  • Kolliz Alan Dzhon
  • Koks Pol Dzhozef
  • Istvud Pol Dzhozef
  • Kharris Nejl Viktor
  • Laj Dzhastin Jeun Kvaj
  • Morli Ehndrju Dehvid
  • Porter Barri
RU2233269C2
AZABICYCLES MODULATING INHIBITION OF CELLULAR ADHESION, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT 1999
  • Burza Zhan-Dominik
  • Kommerson Alen
  • Filosh Brjuno Zhak Kristof
  • Kharris Nejl Viktor
  • Makkarti Klajv
RU2226526C2
THERAPEUTICALLY ACTIVE DERIVATIVES OF OXAZOLINE 2013
  • Kulisa Kler Luiz
  • Brukings Deniel Kristofer
  • Ford Deniel Dzhejms
  • Franklin Richard Dzheremi
  • Rojberson Dzhejms Tomas
  • Gavalkar Anant Ramrao
RU2656209C2
COMBINATION OF INHIBITORS OF FBP-ASE AND SENSITIZING AGENTS OF INSULIN FOR DIABETES MELLITUS TREATMENT 1999
  • Ehrion Mark D.
  • Van Pul'E Paul'
RU2227749C2
THERAPEUTIC AGENT FOR TREATMENT OF DIABETIC PATIENTS 1997
  • Sinkai Khisasi
  • Ozeki Khidekazu
  • Furukava Noboru
RU2174114C2
SOME CHEMICAL COMPOUNDS, COMPOSITIONS AND METHODS 2010
  • Ren Pingda
  • Liu Ji
  • Uilson Troj Edvard
  • Li Liansheng
  • Chan Katrina
  • Rommel Kristian
RU2582676C2
CYCLOPAMINE ANALOGUES 2007
  • Ostehd Brajan K.
  • Benke Mark L.
  • Kastro Al'Fredo K.
  • Sharett Andre B.
  • Grogan Majkl Dzh.
  • Dzhanardanannair Somaradzhannair
  • Leskarbo Andre
  • Peljuzo Stefan
  • Tremblehj Martin R.
RU2486194C2
COMPOSITIONS AND METHODS FOR USING ESTER DERIVATIVES OF BIMATOPROST 2012
  • Vudvard Devid F.
  • Vang Dzhenni V.
  • Garst Majkl E.
  • Berk Robert M.
  • Gek Todd S.
  • Poloso Neil Dzh.
RU2599249C2
IMIDAZOLYL-CYCLIC ACETALS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND TREATMENT METHOD 1998
  • Bamboraf Pol Lindsehj
  • Kollis Alan Dzhon
  • Kholli Frehnk
  • L'Juis Richard Alan
  • Litgoe Dehvid Dzhon
  • Makkenna Dzhehffri Mark
  • Maklehj Jehjn Makfarlejn
  • Porter Barri
  • Rehtkliff Ehndrju Dzhehjms
  • Uollehjs Pol Ehndrju
RU2221795C2
NICOTINAMIDE DERIVATIVES, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND USING 2003
  • Aston Nikola Mehri
  • Bamboro Pol
  • Uoker Ehnn Luiz
RU2309951C2

RU 2 220 954 C2

Authors

Ehstls Piter Charl'Z

Kharris Nejl Viktor

Morli Ehndrju Dehvid

Dates

2004-01-10Published

1998-12-23Filed